DARU-Journal of Pharmaceutical Sciences

Papers
(The H4-Index of DARU-Journal of Pharmaceutical Sciences is 14. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
Hybrid derivatives containing dimethyl fumarate and benzothiazole scaffolds for the potential treatment of multiple sclerosis; in silico & in vivo study61
New psychoactive substances: a multidisciplinary review of challenges and their diverse character32
Multi-functionalization of reduced graphene oxide nanosheets for tumor theragnosis: Synthesis, characterization, enzyme assay, in-silico study, radiolabeling and in vivo targeting evaluation25
Dispersive micro-solid phase extraction based on two MOFs as highly effective adsorbents for analysis of nilotinib in plasma and wastewater23
Effect of vitamins C and E on cancer survival; a systematic review20
Lipid nanoparticles for gene therapy in ocular diseases19
Co-delivery of SN38 and rapamycin albumin bound nanoparticles against breast Cancer19
Evaluation of clinical and safety outcomes of generic tacrolimus (Suprotac $$\circledR$$) versus branded tacrolimus (Prograf $$\circledR$$) in de novo liver transplant patients: a randomized clinical 18
Stearyl amine tailored spanlastics embedded within tetronic® nanogel for boosting the repurposed anticancer potential of mebendazole: formulation, in vitro profiling, cytotoxicity assessment, and in v18
Pharmacogenetic DPYD allele variant frequencies: A comprehensive analysis across an ancestrally diverse Iranian population18
Oral regimen for high dose methotrexate urine alkalinization: a systematic review and meta-analysis17
Impact of concerning excipients on animal safety: insights for veterinary pharmacotherapy and regulatory considerations15
The effect of physical activity on epileptic seizures and consequentlearning and memory impairment in electrical amygdala kindling model15
Cleaning validation in pharmaceutical quality control laboratories: a structured protocol for contamination risk mitigation14
0.034253120422363